Skip to content
scPharmaceuticals Inc icon

scPharmaceuticals Inc

SCPHStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$5.36

Today

+0.0%

YTD

-5.5%

About

scPharmaceuticals Inc., is a biopharmaceutical company known for its revolutionary drug delivery platforms focused on subcutaneous routes. It has built a reputation in the US market for developing transformative pharmaceutical products that enhance patients' care quality and improve health outcomes. Operating within the biotechnology sector, scPharmaceuticals Inc. showcases an impressive repertoire of cutting-edge services. Notably, it is behind the innovative FUROSCIX, a pioneering treatment for heart failure patients. Although autonomously run, scPharmaceuticals is an integral part of the larger healthcare industry. Add SCPH stock to your eToro watchlist today.

Price chart
Closing price history for SCPH (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-3.13
P/S (TTM)6.10
P/B (TTM)-14.18
Market cap$304.36M
Cap tierSmall-cap
Industry avg P/E-43.36

Profitability

Gross margin68.33%
EBIT margin-133.16%
Net margin-112.36%
ROE-934.02%
ROA-125.89%

Earnings & Revenue

Revenue (TTM)$49.97M
Revenue growth (1Y)+107.8%
EPS (TTM)-$1.81
Free cash flow$-65.88M
Total debt$52.45M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.17
Employees164
Next earnings12 Nov '25
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

scPharmaceuticals Inc (SCPH) | Dirk Kuyken